{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:21:07Z","timestamp":1784323267946,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100003516","name":"Winn Feline Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003516","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Veterinary Cardiology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jvc.2023.06.003","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T21:10:16Z","timestamp":1687813816000},"page":"54-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Galectin-3 as a novel biomarker in cats with hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4557-7853","authenticated-orcid":false,"given":"J.P.","family":"Stack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9682-7755","authenticated-orcid":false,"given":"R.C.","family":"Fries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5238-9861","authenticated-orcid":false,"given":"L.","family":"Kruckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kadotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0691-6944","authenticated-orcid":false,"given":"G.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvc.2023.06.003_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1760-2734(06)70051-0","article-title":"Hypertrophic cardiomyopathy. Clinical and pathologic correlates","volume":"5","author":"Fox","year":"2003","journal-title":"J Vet Cardiol"},{"key":"10.1016\/j.jvc.2023.06.003_bib2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O'Hanlon","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2023.06.003_bib3","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s10554-016-0958-1","article-title":"Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients","volume":"32","author":"Hu","year":"2016","journal-title":"Int J Card Imag"},{"key":"10.1016\/j.jvc.2023.06.003_bib4","first-page":"233","article-title":"Galectin-3 levels in patients with hypertrophic cardiomyopathy and its relationship with left ventricular mass index and function","volume":"5","author":"Yakar T\u00fcl\u00fcce","year":"2015","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.jvc.2023.06.003_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00392-010-0125-y","article-title":"Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study","volume":"99","author":"Lok","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jvc.2023.06.003_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/07853890.2010.538080","article-title":"Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction","volume":"43","author":"de Boer","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.jvc.2023.06.003_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00392-012-0500-y","article-title":"Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure","volume":"102","author":"Lok","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jvc.2023.06.003_bib8","first-page":"1","article-title":"The GALA study: relationship between galectin-3 serum levels and short- and long-term outcomes of patients with acute heart failure","author":"Mir\u00f3","year":"2017","journal-title":"Biomarkers"},{"key":"10.1016\/j.jvc.2023.06.003_bib9","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvc.2023.06.003_bib10","first-page":"129","article-title":"Galectin-3: a novel biomarker for the prognosis of heart failure","volume":"90","author":"Amin","year":"2017","journal-title":"Clujul Med"},{"key":"10.1016\/j.jvc.2023.06.003_bib11","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2023.06.003_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","article-title":"Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis","volume":"6","author":"Yu","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jvc.2023.06.003_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"Calvier","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvc.2023.06.003_bib14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.115.05876","article-title":"Cachofeiro, Lopez-Andres N. Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension","volume":"66","author":"Mart\u00ednez-Mart\u00ednez","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.jvc.2023.06.003_bib15","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jvc.2023.06.003_bib16","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/jvim.12215","article-title":"Prognostic indicators in cats with hypertrophic cardiomyopathy","volume":"27","author":"Payne","year":"2013","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2023.06.003_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1939-1676.1993.tb01015.x","article-title":"Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography committee of the specialty of cardiology, American college of veterinary internal medicine","volume":"7","author":"Thomas","year":"1993","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2023.06.003_bib18","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/jvim.16067","article-title":"Cardiac extracellular volume fraction in cats with preclinical hypertrophic cardiomyopathy","volume":"35","author":"Fries","year":"2021","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2023.06.003_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s12917-017-1319-6","article-title":"Assessment of a bedside test for N-terminal pro B-type natriuretic peptide (NT-proBNP) to differentiate cardiac from non-cardiac causes of pleural effusion in cats","volume":"13","author":"Wurtinger","year":"2017","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.jvc.2023.06.003_bib20","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/jvim.14776","article-title":"Investigation of an N-terminal prohormone of brain natriuretic peptide point-of-care ELISA in clinically normal cats and\u00a0cats with cardiac disease","volume":"31","author":"Harris","year":"2017","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2023.06.003_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2460\/javma.243.1.71","article-title":"Clinical usefulness of an assay for measurement of circulating n-terminal pro-b-type natriuretic peptide concentration in dogs and cats with heart disease","volume":"243","author":"Oyama","year":"2013","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.jvc.2023.06.003_bib22","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/jvim.12407","article-title":"Cardiac troponin I and T as prognostic markers in cats with hypertrophic cardiomyopathy","volume":"28","author":"Langhorn","year":"2014","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2023.06.003_bib23","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/jvim.12459","article-title":"Plasma cardiac troponin I concentration and cardiac death in cats with hypertrophic cardiomyopathy","volume":"28","author":"Borgeat","year":"2014","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jvc.2023.06.003_bib24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clinbiochem.2012.09.014","article-title":"Performance characteristics of the architect Galectin-3 assay","volume":"46","author":"La\u2019ulu","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jvc.2023.06.003_bib25","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1111\/jocs.15954","article-title":"Improving the prediction of long-term readmission and mortality using a novel biomarker panel","volume":"36","author":"Brown","year":"2021","journal-title":"J Card Surg"},{"key":"10.1016\/j.jvc.2023.06.003_bib26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.hjc.2017.03.006","article-title":"Serum Galectin-3 and ST2 as predictors of unfavorable outcome in stable dilated cardiomyopathy patients","volume":"58","author":"Wojciechowska","year":"2017","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.jvc.2023.06.003_bib27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ahj.2014.02.011","article-title":"Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials","volume":"167","author":"Meijers","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvc.2023.06.003_bib28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1124\/jpet.114.218370","article-title":"Functions of galectin-3 and its role in fibrotic diseases","volume":"351","author":"Li","year":"2014","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.jvc.2023.06.003_bib29","first-page":"1389","article-title":"Concentrations of galectin-3 in the sera of normal controls and cancer patients","volume":"6","author":"Iurisci","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jvc.2023.06.003_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijcard.2014.09.011","article-title":"Renal function largely influences Galectin-3 prognostic value in heart failure","volume":"177","author":"Zamora","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jvc.2023.06.003_bib31","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/vcp.12085","article-title":"Evaluation of a high-sensitivity assay for measurement of canine and feline serum cardiac troponin I","volume":"42","author":"Langhorn","year":"2013","journal-title":"Vet Clin Pathol"}],"container-title":["Journal of Veterinary Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S176027342300053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S176027342300053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T02:39:55Z","timestamp":1761705595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S176027342300053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":31,"alternative-id":["S176027342300053X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvc.2023.06.003","relation":{},"ISSN":["1760-2734"],"issn-type":[{"value":"1760-2734","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galectin-3 as a novel biomarker in cats with hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Veterinary Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvc.2023.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}